Romosozumab, coming ACR guidelines mark recent high points in osteoporosis

MAUI, HAWAII – The investigational bone-building agent romosozumab provided the therapeutic highlight in the field of osteoporosis during the past year, Dr. Martin J. Bergman said at the 2016...
Source: Rheumatology News - Category: Rheumatology Source Type: research